
EKF Diagnostics Holdings Investor Relations Material
Latest events

H1 2025
EKF Diagnostics Holdings
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from EKF Diagnostics Holdings plc
Access all reports
EKF Diagnostics Holdings plc is a leading in vitro diagnostics company that specializes in the design, development, manufacture, and marketing of diagnostic products, services, and technology for healthcare providers. The company's focus is on point-of-care testing and central laboratory products, including a range of devices and tests for the rapid assessment and monitoring of key markers in blood, such as hemoglobin, glucose, and lactate. EKF Diagnostics serves a global market, providing solutions that support the diagnosis and management of conditions such as diabetes, anemia, and metabolic disorders. The company is headquartered in Cardiff, UK, and its shares are listed on the London Stock Exchange.
Key slides for EKF Diagnostics Holdings plc


H1 2025
EKF Diagnostics Holdings plc


H1 2024
EKF Diagnostics Holdings plc
Latest articles
)
Verisure: Security Leader Ready for a Comeback IPO
Verisure, Europe's leading monitored alarm provider, is preparing a comeback IPO in 2025 that could be one of the year's most significant listings.
16 Sep 2025
)
Stephen J. Squeri: American Express Veteran Chairman and CEO
Stephen Squeri has spent over four decades at American Express, rising through the ranks to lead one of the world's most recognized brands.
15 Sep 2025
)
Where to? The Story of Uber
Uber's journey from rule-breaking disruptor to disciplined dual-app giant, now shaping the future of mobility, delivery, and autonomy.
5 Sep 2025
Ticker symbol
EKF
Country
🇬🇧 United Kingdom